Call Number (LC) Title Results
HE 20.4208/2:An 8/2 Guidelines for the clinical evaluation of antidepressant drugs. 1
HE 20.4208/2:An 8/3 Guidelines for the clinical evaluation of anti-infective drugs (systemic) : adults and children. 1
HE 20.4208/2:An 8/4 Guidelines for the clinical evaluation of antianxiety drugs. 1
HE 20.4208/2:An 8/5 Guidelines for the clinical evaluation of antidiarrheal drugs. 1
HE 20.4208/2:An 8/6 Guidelines for the clinical evaluation of anti-anginal drugs. 1
HE 20.4208/2:An 8/7 Guidelines for the clinical evaluation of anti-inflammatory drugs (adults and children) 1
HE 20.4208/2:An 8/8 Guidelines for the clinical evaluation of anti-arrhythmic drugs. 1
HE 20.4208/2:An 8/9 Guidelines for the clinical evaluation of antacid drugs. 1
HE 20.4208/2:An 8/10 Guidelines for the clinical evaluation of antiepileptic drugs (adults and children) 1
HE 20.4208/2:An 8/11 Guidelines for the clinical evaluation of antineoplastic drugs. 1
HE 20.4208/2:B 78 Guidelines for the clinical evaluation of bronchodilator drugs. 1
HE 20.4208/2:C 19 Guidelines for the clinical evaluation of drugs to prevent dental caries. 1
HE 20.4208/2:C 61 General considerations for the clinical evaluation of drugs. 1
HE 20.4208/2:G 21 Guidelines for the clinical evaluation of gastric secretory depressant (GSD) drugs. 1
HE 20.4208/2:G 21/2 Guidelines for the clinical evaluation of G.I. motility-modifying drugs. 1
HE 20.4208/2:H 99 Guidelines for the clinical evaluation of hypnotic drugs. 1
HE 20.4208/2:In 3 General considerations for the clinical evaluation of drugs in infants and children. 1
HE 20.4208/2:L 45 Guidelines for the clinical evaluation of laxative drugs. 1
HE 20.4208/2:L 66 Guidelines for the clinical evaluation of lipid-altering agents in adults and children. 1
HE 20.4208/2:Os 7 Guidelines for the clinical evaluation of drugs used in the treatment of osteoporosis. 1